1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Chronic Disease Market Trends
  5. > Coronary Artery Disease (CAD) (Ischemic Heart Disease) Global Clinical Trials Review, H2, 2014

Coronary Artery Disease (CAD) (Ischemic Heart Disease) Global Clinical Trials Review, H2, 2014

Summary

GlobalData's clinical trial report, “Coronary Artery Disease (CAD) (Ischemic Heart Disease) Global Clinical Trials Review, H2, 2014" provides data on the Coronary Artery Disease (CAD) (Ischemic Heart Disease) clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Coronary Artery Disease (CAD) (Ischemic Heart Disease). It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Coronary Artery Disease (CAD) (Ischemic Heart Disease). This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table Of Contents

Coronary Artery Disease (CAD) (Ischemic Heart Disease) Global Clinical Trials Review, H2, 2014
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 7
Coronary Artery Disease (CAD) (Ischemic Heart Disease) 7
Report Guidance 7
Clinical Trials by Region 8
Clinical Trials and Average Enrollment by Country 9
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11
Top Five Countries Contributing to Clinical Trials in Europe 12
Top Countries Contributing to Clinical Trials in North America 13
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 14
Top Five Countries Contributing to Clinical Trials in Central and South America 15
Clinical Trials by G7 Countries: Proportion of Coronary Artery Disease (CAD) (Ischemic Heart Disease) to Cardiovascular Clinical Trials 16
Clinical Trials by Phase in G7 Countries 17
Clinical Trials in G7 Countries by Trial Status 18
Clinical Trials by E7 Countries: Proportion of Coronary Artery Disease (CAD) (Ischemic Heart Disease) to Cardiovascular Clinical Trials 19
Clinical Trials by Phase in E7 Countries 20
Clinical Trials in E7 Countries by Trial Status 21
Clinical Trials by Phase 22
In Progress Trials by Phase 23
Clinical Trials by Trial Status 24
Clinical Trials by End Point Status 25
Unaccomplished Trials of Coronary Artery Disease (CAD) (Ischemic Heart Disease) 26
Subjects Recruited Over a Period of Time 35
Clinical Trials by Sponsor Type 36
Prominent Sponsors 37
Top Companies Participating in Coronary Artery Disease (CAD) (Ischemic Heart Disease) Therapeutics Clinical Trials 38
Prominent Drugs 40
Clinical Trial Profiles 41
Clinical Trial Overview of Top Companies 41
AstraZeneca PLC 41
Clinical Trial Overview of AstraZeneca PLC 41
Pfizer Inc. 44
Clinical Trial Overview of Pfizer Inc. 44
Daiichi Sankyo Company, Limited 46
Clinical Trial Overview of Daiichi Sankyo Company, Limited 46
Abbott Laboratories 48
Clinical Trial Overview of Abbott Laboratories 48
Bristol-Myers Squibb Company 50
Clinical Trial Overview of Bristol-Myers Squibb Company 50
Astellas Pharma Inc. 52
Clinical Trial Overview of Astellas Pharma Inc. 52
Medtronic, Inc. 54
Clinical Trial Overview of Medtronic, Inc. 54
Boston Scientific Corporation 56
Clinical Trial Overview of Boston Scientific Corporation 56
Merck and Co., Inc. 58
Clinical Trial Overview of Merck and Co., Inc. 58
Eli Lilly and Company 60
Clinical Trial Overview of Eli Lilly and Company 60
Clinical Trial Overview of Top Institutes / Government 62
National Heart, Lung, and Blood Institute 62
Clinical Trial Overview of National Heart, Lung, and Blood Institute 62
Seoul National University Hospital 65
Clinical Trial Overview of Seoul National University Hospital 65
Yonsei University 67
Clinical Trial Overview of Yonsei University 67
Cardiovascular Research Foundation 69
Clinical Trial Overview of Cardiovascular Research Foundation 69
Kumamoto University 71
Clinical Trial Overview of Kumamoto University 71
University of Florida 73
Clinical Trial Overview of University of Florida 73
Tehran University of Medical Sciences 74
Clinical Trial Overview of Tehran University of Medical Sciences 74
Emory University 75
Clinical Trial Overview of Emory University 75
Medical University of Vienna 76
Clinical Trial Overview of Medical University of Vienna 76
Kyoto University 77
Clinical Trial Overview of Kyoto University 77
Five Key Clinical Profiles 78
Appendix 98
Abbreviations 98
Definitions 98
Research Methodology 99
Secondary Research 99
About GlobalData 100
Contact Us 100
Disclaimer 100
Source 100

List of Tables
Coronary Artery Disease (CAD) (Ischemic Heart Disease) Therapeutics, Global, Clinical Trials by Region, 2014* 8
Coronary Artery Disease (CAD) (Ischemic Heart Disease) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 9
Coronary Artery Disease (CAD) (Ischemic Heart Disease) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 10
Coronary Artery Disease (CAD) (Ischemic Heart Disease) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014* 11
Coronary Artery Disease (CAD) (Ischemic Heart Disease) Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 12
Coronary Artery Disease (CAD) (Ischemic Heart Disease) Therapeutics Clinical Trials, North America, Top Countries, 2014* 13
Coronary Artery Disease (CAD) (Ischemic Heart Disease) Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2014* 14
Coronary Artery Disease (CAD) (Ischemic Heart Disease) Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2014* 15
Proportion of Coronary Artery Disease (CAD) (Ischemic Heart Disease) to Cardiovascular Clinical Trials, G7 Countries (%), 2014* 16
Coronary Artery Disease (CAD) (Ischemic Heart Disease) Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 17
Coronary Artery Disease (CAD) (Ischemic Heart Disease) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 18
Proportion of Coronary Artery Disease (CAD) (Ischemic Heart Disease) to Cardiovascular Clinical Trials, E7 Countries (%), 2014* 19
Coronary Artery Disease (CAD) (Ischemic Heart Disease) Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 20
Coronary Artery Disease (CAD) (Ischemic Heart Disease) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 21
Coronary Artery Disease (CAD) (Ischemic Heart Disease) Therapeutics, Global, Clinical Trials by Phase, 2014* 22
Coronary Artery Disease (CAD) (Ischemic Heart Disease) Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 23
Coronary Artery Disease (CAD) (Ischemic Heart Disease) Therapeutics, Global, Clinical Trials by Trial Status, 2014* 24
Coronary Artery Disease (CAD) (Ischemic Heart Disease) Therapeutics Clinical Trials, Global, by End Point Status, 2014* 25
Coronary Artery Disease (CAD) (Ischemic Heart Disease) Therapeutics, Global, Suspended Clinical Trials, 2014* 26
Coronary Artery Disease (CAD) (Ischemic Heart Disease) Therapeutics, Global, Withdrawn Clinical Trials, 2014* 27
Coronary Artery Disease (CAD) (Ischemic Heart Disease) Therapeutics, Global, Terminated Clinical Trials, 2014* 29
Coronary Artery Disease (CAD) (Ischemic Heart Disease) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 35
Coronary Artery Disease (CAD) (Ischemic Heart Disease) Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 36
Coronary Artery Disease (CAD) (Ischemic Heart Disease) Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 37
Coronary Artery Disease (CAD) (Ischemic Heart Disease) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 39
Coronary Artery Disease (CAD) (Ischemic Heart Disease) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 40
Coronary Artery Disease (CAD) (Ischemic Heart Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2014* 41
Coronary Artery Disease (CAD) (Ischemic Heart Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2014* 44
Coronary Artery Disease (CAD) (Ischemic Heart Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Daiichi Sankyo Company, Limited, 2014* 46
Coronary Artery Disease (CAD) (Ischemic Heart Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Abbott Laboratories, 2014* 48
Coronary Artery Disease (CAD) (Ischemic Heart Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Bristol-Myers Squibb Company, 2014* 50
Coronary Artery Disease (CAD) (Ischemic Heart Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Astellas Pharma Inc., 2014* 52
Coronary Artery Disease (CAD) (Ischemic Heart Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Medtronic, Inc., 2014* 54
Coronary Artery Disease (CAD) (Ischemic Heart Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Boston Scientific Corporation, 2014* 56
Coronary Artery Disease (CAD) (Ischemic Heart Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck and Co., Inc., 2014* 58
Coronary Artery Disease (CAD) (Ischemic Heart Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Eli Lilly and Company, 2014* 60
Coronary Artery Disease (CAD) (Ischemic Heart Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by National Heart, Lung, and Blood Institute, 2014* 62
Coronary Artery Disease (CAD) (Ischemic Heart Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Seoul National University Hospital, 2014* 65
Coronary Artery Disease (CAD) (Ischemic Heart Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Yonsei University, 2014* 67
Coronary Artery Disease (CAD) (Ischemic Heart Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Cardiovascular Research Foundation, 2014* 69
Coronary Artery Disease (CAD) (Ischemic Heart Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Kumamoto University, 2014* 71
Coronary Artery Disease (CAD) (Ischemic Heart Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Florida, 2014* 73
Coronary Artery Disease (CAD) (Ischemic Heart Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Tehran University of Medical Sciences, 2014* 74
Coronary Artery Disease (CAD) (Ischemic Heart Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Emory University, 2014* 75
Coronary Artery Disease (CAD) (Ischemic Heart Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Medical University of Vienna, 2014* 76
Coronary Artery Disease (CAD) (Ischemic Heart Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Kyoto University, 2014* 77

List of Figures
Coronary Artery Disease (CAD) (Ischemic Heart Disease) Therapeutics, Global, Clinical Trials by Region (%), 2014* 8
Coronary Artery Disease (CAD) (Ischemic Heart Disease) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 9
Coronary Artery Disease (CAD) (Ischemic Heart Disease) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 10
Coronary Artery Disease (CAD) (Ischemic Heart Disease) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014* 11
Coronary Artery Disease (CAD) (Ischemic Heart Disease) Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 12
Coronary Artery Disease (CAD) (Ischemic Heart Disease) Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 13
Coronary Artery Disease (CAD) (Ischemic Heart Disease) Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2014* 14
Coronary Artery Disease (CAD) (Ischemic Heart Disease) Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2014* 15
Proportion of Coronary Artery Disease (CAD) (Ischemic Heart Disease) to Cardiovascular Clinical Trials, G7 Countries (%), 2014* 16
Coronary Artery Disease (CAD) (Ischemic Heart Disease) Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 17
Coronary Artery Disease (CAD) (Ischemic Heart Disease) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 18
Proportion of Coronary Artery Disease (CAD) (Ischemic Heart Disease) to Cardiovascular Clinical Trials, E7 Countries (%), 2014* 19
Coronary Artery Disease (CAD) (Ischemic Heart Disease) Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 20
Coronary Artery Disease (CAD) (Ischemic Heart Disease) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 21
Coronary Artery Disease (CAD) (Ischemic Heart Disease) Therapeutics, Global, Clinical Trials by Phase (%), 2014* 22
Coronary Artery Disease (CAD) (Ischemic Heart Disease) Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 23
Coronary Artery Disease (CAD) (Ischemic Heart Disease) Therapeutics, Global, Clinical Trials by Trial Status, 2014* 24
Coronary Artery Disease (CAD) (Ischemic Heart Disease) Therapeutics Clinical Trials, Global, by End Point Status, 2014* 25
Coronary Artery Disease (CAD) (Ischemic Heart Disease) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 35
Coronary Artery Disease (CAD) (Ischemic Heart Disease) Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 36
Coronary Artery Disease (CAD) (Ischemic Heart Disease) Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 37
Coronary Artery Disease (CAD) (Ischemic Heart Disease) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 38
Coronary Artery Disease (CAD) (Ischemic Heart Disease) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 40
GlobalData Methodology 99

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Vascular Graft Market: By Raw Material (Polyester, Polytetrafluoroethylene, Others); By Product (Hemodialysis Access, Endovascular Stent, Others); By Application (Cardiovascular Diseases, Cardiac Aneurysm, Others) & By Region-Forecast (2016-2022)

Vascular Graft Market: By Raw Material (Polyester, Polytetrafluoroethylene, Others); By Product (Hemodialysis Access, Endovascular Stent, Others); By Application (Cardiovascular Diseases, Cardiac Aneurysm, Others) & By Region-Forecast (2016-2022)

  • $ 5422
  • Industry report
  • September 2016
  • by Industry ARC

Vascular graft procedures are minimally invasive besides involving repairing vessels from the inside as compared to other conventional vascular surgical procedure.In vascular graft procedures, Catheter-based ...

Global Cardiovascular Disease Market to 2022 - Sanofi and Novartis to Become Market Leaders as Praluent and Entresto Drive Revenue Growth

Global Cardiovascular Disease Market to 2022 - Sanofi and Novartis to Become Market Leaders as Praluent and Entresto Drive Revenue Growth

  • $ 4995
  • Industry report
  • October 2016
  • by GBI Research

Global Cardiovascular Disease Market to 2022 - Sanofi and Novartis to Become Market Leaders as Praluent and Entresto Drive Revenue Growth Summary Cardiovascular disease (CVD) covers a range of difference ...

Global Left Atrial Appendage Closure Market 2017-2021

Global Left Atrial Appendage Closure Market 2017-2021

  • $ 3500
  • Industry report
  • January 2017
  • by Infiniti Research Limited

About Left Atrial Appendage Closure Atrial fibrillation is one of the most common types of arrhythmia and is characterized by fast and irregular heart rhythms. The atria of patients suffering from the ...


ref:plp2014

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.